Sunshine Biopharma Inc (SBFM)

[TenKay]

The question of materiality is left up to the company. The Form 8K outlines some specific events that must be reported, but also has a catch all “other” category.

The rule of thumb is, if something has happened that can reasonably be expected to affect the stock price it should be reported.

Now…what I think you are referring to are things like forward looking statements, updates, and frankly “hype”.

If it is “immaterial” then it really doesn’t matter in the big picture…and while such “immaterial” information may have an impact on an OTC stock…Nasdaq doesn’t operate the same way…which is why some may be yearning for the old OTC days at some point.

The biggest challenge they are going to face is funding…and like any real pharmaceutical company that could mean $100’s of millions if they were serious.

I don’t know if a single uplisted OTC stock that has achieved that.

But they will be having to sell a lot of equity over the coming months and years…and between that and the warrants it will be a very very strong headwind for the pps.